» Articles » PMID: 32668703

C3 Opsonization of Anthrax Bacterium and Peptidoglycan Supports Recognition and Activation of Neutrophils

Overview
Journal Microorganisms
Specialty Microbiology
Date 2020 Jul 17
PMID 32668703
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophils are the most abundant innate cell population and a key immune player against invading pathogens. Neutrophils can kill both bacterium and spores of , the causative anthrax pathogen. Unlike interactions with professional phagocytes, the molecular recognition of anthrax by neutrophils is largely unknown. In this study, we investigated the role of complement C3 deposition on anthrax particles for neutrophil recognition of bacterium and/or its cell wall peptidoglycan, an abundant pathogen-associated molecular pattern that supports anthrax sepsis. C3 opsonization and recognition by complement receptors accounted for 70-80% of the affinity interactions between neutrophils and anthrax particles at subphysiologic temperatures. In contrast, C3 supported up to 50% of the anthrax particle ingestion under thermophysiologic conditions. Opsonin-dependent low affinity interactions and, to a lower extent, opsonin-independent mechanisms, provide alternative entry routes. Similarly, C3 supported 58% of peptidoglycan-induced degranulation and, to a lower extent, 23% of bacterium-induced degranulation. Interestingly, an opsonin independent mechanism mediated by complement C5, likely through C5a anaphylatoxin, primes azurophilic granules in response to anthrax particles. Overall, we show that C3 deposition supports anthrax recognition by neutrophils but is dispensable for pathogen ingestion and neutrophil degranulation, highlighting immune recognition redundancies that minimize the risk of pathogen evasion.

Citing Articles

Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3.

Mytych J, Pan Z, Lopez-Davis C, Redinger N, Lawrence C, Ziegler J Immunohorizons. 2024; 8(3):269-280.

PMID: 38517345 PMC: 10985058. DOI: 10.4049/immunohorizons.2300109.


Internalization of Polymeric Bacterial Peptidoglycan Occurs through Either Actin or Dynamin Dependent Pathways.

Popescu N, Cochran J, Duggan E, Kluza J, Silasi R, Coggeshall K Microorganisms. 2022; 10(3).

PMID: 35336127 PMC: 8951193. DOI: 10.3390/microorganisms10030552.


Mechanism of Action of Monoclonal Antibodies That Block the Activity of the Lethal Toxin of Bacillus Anthracis.

Romanenko Y, Riabko A, Marin M, Kartseva A, Silkina M, Shemyakin I Acta Naturae. 2022; 13(4):98-104.

PMID: 35127153 PMC: 8807536. DOI: 10.32607/actanaturae.11387.


Efferocytosis and Anthrax: Implications for Bacterial Sepsis?.

Mytych J, Pan Z, Farris A J Cell Immunol. 2021; 3(3):133-139.

PMID: 34708219 PMC: 8547791. DOI: 10.33696/immunology.3.090.


Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons.

Keshari R, Popescu N, Silasi R, Regmi G, Lupu C, Simmons J Proc Natl Acad Sci U S A. 2021; 118(37).

PMID: 34507997 PMC: 8449412. DOI: 10.1073/pnas.2104347118.

References
1.
Cleret A, Quesnel-Hellmann A, Vallon-Eberhard A, Verrier B, Jung S, Vidal D . Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol. 2007; 178(12):7994-8001. DOI: 10.4049/jimmunol.178.12.7994. View

2.
Coggeshall K, Lupu F, Ballard J, Metcalf J, James J, Farris D . The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax. J Cell Mol Med. 2013; 17(7):914-20. PMC: 3729634. DOI: 10.1111/jcmm.12075. View

3.
Hayashi F, Means T, Luster A . Toll-like receptors stimulate human neutrophil function. Blood. 2003; 102(7):2660-9. DOI: 10.1182/blood-2003-04-1078. View

4.
Gasque P . Complement: a unique innate immune sensor for danger signals. Mol Immunol. 2004; 41(11):1089-98. DOI: 10.1016/j.molimm.2004.06.011. View

5.
Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, Montagnoli C . TLRs govern neutrophil activity in aspergillosis. J Immunol. 2004; 173(12):7406-15. DOI: 10.4049/jimmunol.173.12.7406. View